Literature DB >> 9405025

Insulin-like growth factors and their binding proteins in pleural fluid.

Y Le Bouc1, A Bellocq, C Philippe, L Perin, M Garabedian, B Fouqueray, C Zacharias, J Cadranel, L Baud.   

Abstract

We investigated the expression and potential regulatory role of insulin-like growth factors (IGFs) and their specific binding proteins (BPs) in tuberculous and nontuberculous pleuritis. By using a radioimmunoassay after acid gel filtration chromatography, we found that mean concentrations of IGF-I were 211.9 +/- 20.2 microg/l and 203.2 +/- 31.1 microg/l in pleural fluid of 14 patients with tuberculous pleuritis and 9 patients with malignant pleuritis respectively. These values were near those in serum of the same patients (221.3 +/- 19.5 microg/l and 204.6 +/- 21.0 microg/l respectively). By using a specific protein-binding assay, we found that mean concentrations of IGF-II were 345.3 +/- 61.0 microg/l and 167.6 +/- 22.7 microg/l in tuberculous and malignant pleural effusions respectively. These values were significantly lower than those in serum of the same patients (628.3 +/- 79.0 microg/l, P<0.025 and 532.0 +/- 85.9 microg/l, P<0.025 respectively). Because bioavailability and bioactivity of IGFs may be regulated by their binding to IGFBPs, we studied IGFBP patterns in the pleural fluid of 6 patients with tuberculous pleuritis. As assessed by Western ligand blotting the levels of IGFBP-1 and IGFBP-2 were increased whereas those of IGFBP-3 were decreased in pleural fluid in comparison with serum. The decrease in IGFPB-3 levels reflected increased proteolysis, as assessed by Western immunoblotting. In spite of this presence of IGFBPs, IGFs could be responsible for the local biosynthesis of 1.25-dihydroxyvitamin D (1,25-(OH)2D) since pleural fluid levels of both IGF-I and IGF-II significantly correlated with those of 1,25-(OH)2D. These results indicate that IGFs are detectable in pleural fluid and may contribute to control the activity of 25-hydroxyvitamin D-1alpha hydroxylase in tuberculous pleuritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405025     DOI: 10.1530/eje.0.1370467

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  3 in total

1.  Reactive oxygen metabolites can be used to differentiate malignant and non-malignant pleural efffusions.

Authors:  Ufuk Cobanoglu; Fuat Sayir; Duygu Mergan
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

2.  Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals.

Authors:  Jacqueline M Achkar; Laetitia Cortes; Pascal Croteau; Corey Yanofsky; Marija Mentinova; Isabelle Rajotte; Michael Schirm; Yiyong Zhou; Ana Paula Junqueira-Kipnis; Victoria O Kasprowicz; Michelle Larsen; René Allard; Joanna Hunter; Eustache Paramithiotis
Journal:  EBioMedicine       Date:  2015-07-30       Impact factor: 8.143

3.  Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis.

Authors:  Komal Kedia; Jason P Wendler; Erin S Baker; Kristin E Burnum-Johnson; Leah G Jarsberg; Kelly G Stratton; Aaron T Wright; Paul D Piehowski; Marina A Gritsenko; David M Lewinsohn; George B Sigal; Marc H Weiner; Richard D Smith; Jon M Jacobs; Payam Nahid
Journal:  Tuberculosis (Edinb)       Date:  2018-07-18       Impact factor: 3.131

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.